Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30?Expressing Non-Hodgkin Lymphomas:Results of a Multicenter, Open-Labeled Phase II Trial
- Publisher
- CANCER RESEARCH AND TREATMENT
- Language
- 영어
- ISSN
- 1598-2998
- Citation Volume
- 52
- Citation Number
- 2
- Citation Start Page
- 374
- Citation End Page
- 387
-
Appears in Collections:
- Medicine > Medicine
- Authorize & License
-
- Files in This Item:
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.